Categories: Medical Devices

Earlier this month, Customed, Inc. initiated the largest medical device recall ever recorded in FDA history.  The recall was of sterile convenience surgical packs and was due to packaging flaws.  These flaws could result in loss of sterility and lead to infection.  There have also been a number of voluntary recalls on the drug side related to sterility.  FDA has also issued warning letters to pharmaceutical companies for poor aseptic practices, among other Good Manufacturing Practices (cGMP) related issues.  These headlines should remind the medical device and pharmaceutical industry of the importance of sterility and the renewed focus the government has with respect to these issues.

How does a company decide what aspects of sterility to focus on to ensure their processes are aligned with FDA's current thinking?

  • Constantly Review Recent Warning Letters:  This can give you a road map as to what FDA is looking into when conducting an inspection.  Determine the issues other companies faced and ensure your systems address these issues.
  • Be Aware of Recent Recalls:  Ensure that your company understands the reasoning behind the recalls and if similarities exist between your processes/products and the company that is initiating the recall, assess whether changes need to be made within your organization.
  • Be aware of the most recent FDA Guidance Documents
  • Be aware of the most up-to-date ISO standards

It is important to note that violations of sterility may not only expose companies to potential liability under the FD&C Act, but also has the potential to lead to allegations that violations of the FD&C Act caused false claims to be submitted in violation of the False Claims Act (FCA).  Historically, manufacturer's exposure under the FCA was based on allegations of off-label promotion or alleged anti-kickback violations.  However, in 2010 that changed when GMP violations served as one of the basis of liability in the GlaxoSmithKline $600 million settlement.  This month, a complaint was filed against Gilead Sciences, Inc. alleging the company's failure to comply with the FD&C Act resulted in FCA violations.  Specifically, the complaint alleges that the company caused the submission of false claims by selling products that lacked potency and were contaminated with filth, metal and microbes.  At the same time, a recent court case has called into question the extent to which GMP violations can cause a claim to be false or fraudulent.

Given these actions, pharmaceutical and medical device manufacturers should pay close attention to the possibility of not only being subject to heightened FDA enforcement, but also possibly having to defend themselves against allegations under the FCA.

Back to Health Law Advisor Blog

Search This Blog

Blog Editors

Related Services



Jump to Page


Sign up to receive an email notification when new Health Law Advisor posts are published:

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.